← 返回首页
美国 · 通讯社与实时数据 · PR Newswire

Neurocrine Biosciences Reports Third-Quarter 2026 Financial Results

来源：PR Newswire · 美国 2 小时前

Total Third-Quarter 2026 Revenue Grew 41% Year-Over-Year to $1.1 Billion INGREZZA® (valbenazine) 2026 Net Sales Guidance Raised to $2.9 to $2.925 Billion SAN DIEGO, Nov. 2, 2026…

在 PR Newswire 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.prnewswire.com)

推荐阅读

Associated Press (Business)

8 innovative gifts meant to change up how we drive, cook, sleep and more

 Dow Jones Newswires

Rethinking AI in Enterprise Intelligence

 MT Newswires

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows